RankingsPricing
  1. US-listed companies
  2. OCULAR THERAPEUTIX, INC
  3. Financials
  4. Net income margin (%)

OCULAR THERAPEUTIX, INCOCUL

Market cap
$2.3B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 2024-303.7+119.82%
Dec 31, 2023-138.1+0.14%
Dec 31, 2022-138+816.23%
Dec 31, 2021-15.1-98.32%
Dec 31, 2020-894.3-143.77%
Dec 31, 20192,043.3-167.80%
Dec 31, 2018-3,014-8.56%
Dec 31, 2017-3,296.2+39.14%
Dec 31, 2016-2,369+4.30%
Dec 31, 2015-2,271.3-38.79%
Dec 31, 2014-3,710.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)